Iizasa T, Suzuki M, Yoshida S, et al Prediction of prognosis and surgical indications for pulmonary metastasectomy
from colorectal cancer.
1) was confirmed by metastasectomy
, and the patient was administered with cisplatin-based chemotherapy.
5 y 2005 ifosfamide/ doxorubicin) + Surg + rxt Folpe et al, (21) 59 Surg + cht 30 mo 2005 36 Surg + cht 39 mo 56 Surg + cht + rxt 11 mo Armah et al, (22) 59 Surg for the primary 99 mo 2007 tumor and mts Bleeker et al, (23) 50 Surg 18 mo 2012 Liu et al, (24) 33 NeCht + surg + cht 8 mo 2009 (epirubicin + cisplatin + ifosfamide) Yamashita and 42 Surg + cht 22 mo Fletcher, (25) 2010 Cossu et al, (26) 52 Surg 60 mo 2014 Kang et al, (27) 49 Surg + cht (doxorubicin 7 mo 2014 hydrochloride + haloxan) Italiano et al, (28) 69 Surg + mTOR inhibitor 9 mo 2010 + metastasectomy
55 Sug + metastasectomy
have suggested that surgical intervention with metastasectomy
plus chemotherapy in advanced gastric cancer patients with KT can improve their OS.
RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy
," International Journal of Cancer, vol.
Morton, "Does metastasectomy
improve survival in patients with stage IV melanoma?
FDG PET/CT is recommended in select cases where metastasectomy
is planned, to exclude disease that might make surgery inappropriate.
8) The authors suggested that a metastasectomy
would improve the effectiveness of radioiodine administration postoperatively thus providing a discrete improvement in the patient's survival rate.
Twelve out of 27(44%) patients with lung-only metastases underwent successful metastasectomy
In patients with DTC complicated with bone metastases, treatment modalities should include total thyroidectomy, metastasectomy
-if possible-, RAI therapy, and external radiation therapy (8).
The numerous sites of pulmonary metastases precluded metastasectomy
PET has been shown to be more sensitive than conventional imaging for detecting extrahepatic metastatic disease in patients considered for liver metastasectomy
, and has the potential to alter treatment in up to 27% of patients.